Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

Francesco Merli, Stefano Luminari, Fiorella Ilariucci, Mario Petrini, Carlo Visco, Achille Ambrosetti, Caterina Stelitano, Francesco Caracciolo, Nicola di Renzo, Francesco Angrilli, Angelo M. Carella, Isabella Capodanno, Elisa Barbolini, Sara Galimberti, Massimo Federico

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi'. Together they form a unique fingerprint.

Medicine & Life Sciences